This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Central Core Myopathy (disorder)
Information about Central Core Myopathy (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Central Core Myopathy (disorder)
Most recent studies have shown that Central Core Myopathy (disorder) shares some biological mechanisms with atrophy, cardiomyopathies, congenital-myopathy-(disorder), congenital-structural-myopathy, dystrophy, malignant-hyperpyrexia-due-to-anesthesia, malignant-paraganglionic-neoplasm, multi-core-congenital-myopathy, muscle-contracture, muscle-hypotonia, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathies-nemaline, myopathy, myotonic-dystrophy, neuromuscular-diseases, scoliosis-unspecified, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Central Core Myopathy (disorder), and have been seen in publications frequently: Aging, Cell Migration, Fertilization, Gene Silencing, Hypersensitivity, Innervation, Localization, Membrane Depolarization, Muscle Atrophy, Muscle Contraction, Myoblast Fusion, Ossification, Oxidative Phosphorylation, Pathogenesis, Regulation Of Gene Expression, Relaxation Of Skeletal Muscle, Response To Caffeine, Reverse Transcription, Skeletal Muscle Contraction, Transport
Quite a number of genes have been found to play important roles in Central Core Myopathy (disorder), such as ACTA1, CACNA1S, CHKA, CHKB, DES, DLD, DMPK, MTM1, MYOT, NEB, QPCT, RUNX2, RYR1, RYR2, SCTR, SNCG, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.